Neuronal mechanisms underlying attention deficit hyperactivity disorder: The influence of arousal on prefrontal cortical function

Annals of the New York Academy of Sciences

Volumn 1129, Issue , 2008, Pages 236-245

  Brennan, Avis R ^a   Arnsten, Amy F T ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attention; Cognition; Dopamine; Norepinephrine; Prefrontal cortex; Stress

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; AMPHETAMINE; ATOMOXETINE; BETA 1 ADRENERGIC RECEPTOR; CATECHOLAMINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; GUANFACINE; METHYLPHENIDATE; NEUROTRANSMITTER; NORADRENALIN;

AROUSAL; ASSOCIATION CORTEX; ATTENTION DEFICIT DISORDER; BASAL GANGLION; BEHAVIOR; BRAIN CORTEX; BRAIN FUNCTION; CEREBELLUM; COGNITION; CONFERENCE PAPER; ELECTROPHYSIOLOGY; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; HUMAN; HYPERACTIVITY; IMPULSIVENESS; LOCOMOTION; MEMORY DISORDER; MODULATION; MUTATION; NERVE CELL NETWORK; NERVE CONDUCTION; PARIETAL LOBE; PREFRONTAL CORTEX; TEMPORAL CORTEX; WORKING MEMORY; ENVIRONMENT; GENETICS; METABOLISM; NERVE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANIMALIA;

AROUSAL; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CATECHOLAMINES; ENVIRONMENT; HUMANS; NEURONS; PREFRONTAL CORTEX;

EID: 47249118841     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1417.007     Document Type: Conference Paper

References (105)

1. Giedd, J.N. et al. 2001. Brain imaging of attention deficit/hyperactivity disorder. Ann. N. Y. Acad. Sci. 931 : 33 49.
2. Aron, A.R. & R.A. Poldrack. 2005. The cognitive neuroscience of response inhibition: relevance for genetic research in attention-deficit/ hyperactivity disorder. Biol. Psychiatry 57 : 1285 1292.
3. Goldman-Rakic, P.S. 1987. Circuitry of the primate prefrontal cortex and the regulation of behavior by representational memory. In Handbook of Physiology, The Nervous System, Higher Functions of the Brain, Vol. V. F. Plum, Ed 373 417. American Physiological Society. Bethesda, MD.
4. Barbas, H. et al. 2005. Relationship of prefrontal connections to inhibitory systems in superior temporal areas in the rhesus monkey. Cereb. Cortex. 15 : 1356 1370.
5. Rauschecker, J.P. & B. Tian. 2000. Mechanisms and streams for processing of "what" and "where" in auditory cortex. Proc. Natl. Acad. Sci. USA 97 : 11800 11806.
6. Desimone, R. 1996. Neural mechanisms for visual memory and their role in attention. Proc. Natl. Acad. Sci. USA 93 : 13494 13499.
7. Kastner, S. et al. 1998. Mechanisms of directed attention in the human extrastriate cortex as revealed by functional MRI. Science 282 : 108 111.
8. Coull, J.T. & A.C. Nobre. 1998. Where and when to pay attention: the neural systems for directing attention to spatial locations and to time intervals as revealed by both PET and fMRI. J. Neurosci. 18 : 7426 7435.
9. Mesulam, M.-M. 2000. Principles of Behavioral and Cognitive Neurology. Oxford University Press. New York.
10. Crowe, D.A. et al. 2004. Neural activity in primate parietal area 7a related to spatial analysis of visual mazes. Cereb. Cortex 14 : 23 34.
11. Snyder, L.H. et al. 1998. Separate body- and world-referenced representations of visual space in parietal cortex. Nature 394 : 887 891.
12. Goldman-Rakic, P.S. 1995. Cellular basis of working memory. Neuron 14 : 477 485.
13. Miller, E.K., L. Li & R. Desimone. 1993. Activity of neurons in anterior inferior temporal cortex during a short-term memory task. J. Neurosci. 13 : 1460 1478.
14. Funahashi, S., M.V. Chafee & P.S. Goldman-Rakic. 1993. Prefrontal neuronal activity in rhesus monkeys performing a delayed anti-saccade task. Nature 365 : 753 756.
15. Castellanos, F.X. et al. 1996. Quantitative brain magnetic resonance imaging in attention deficit/hyperactivity disorder. Arch. Gen. Psychiatry 53 : 607 616.
16. Casey, B.J. et al. 1997. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 36 : 374 383.
17. Sowell, E.R. et al. 2003. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362 : 1699 1707.
18. Itami, S. & H. Uno. 2002. Orbitofrontal cortex dysfunction in attention-deficit hyperactivity disorder revealed by reversal and extinction tasks. Neuroreport 13 : 2453 2457.
19. Bedard, A.C. et al. 2003. Selective inhibition in children with attention-deficit hyperactivity disorder off and on stimulant medication. J. Abnorm. Child Psychol. 31 : 315 327.
20. McLean, A. et al. 2004. Characteristic neurocognitive profile associated with adult attention-deficit/hyperactivity disorder. Psychol. Med. 34 : 681 692.
21. Aron, A.R., T.W. Robbins & R.A. Poldrack. 2004. Inhibition and the right inferior frontal cortex. Trends Cogn. Sci. 8 : 170 177.
22. Wilkins, A.J., T. Shallice & R. McCarthy. 1987. Frontal lesions and sustained attention. Neuropsychologia 25 : 359 365.
23. Godefroy, O. & M. Rousseaux. 1996. Divided and focused attention in patients with lesion of the prefrontal cortex. Brain Cogn. 30 : 155 174.
24. Bartus, R.T. & T.E. Levere. 1977. Frontal decortication in rhesus monkeys: a test of the interference hypothesis. Brain Res. 119 : 233 248.
25. Birrell, J.M. & V.J. Brown. 2000. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J. Neurosci. 20 : 4320 4324.
26. Berquin, P.C. et al. 1998. Cerebellum in attention-deficit hyperactivity disorder: a morphometric MRI study. Neurology 50 : 1087 1093.
27. Seidman, L.J., E.M. Valera & N. Makris. 2005. Structural brain imaging of attention-deficit/hyperactivity disorder. Biol. Psychiatry 57 : 1263 1272.
28. Castellanos, F.X. et al. 2002. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 288 : 1740 1748.
29. Dum, R.P., C. Li & P.L. Strick. 2002. Motor and nonmotor domains in the monkey dentate. Ann. N. Y. Acad. Sci. 978 : 289 301.
30. Hoshi, E. et al. 2005. The cerebellum communicates with the basal ganglia. Nat. Neurosci. 8 : 1491 1493.
31. Mouradian, R.D., F.M. Seller & B.D. Waterhouse. 1991. Noradrenergic potentiation of excitatory transmitter action in cerebrocortical slices: evidence of mediation by an alpha1-receptor-linked second messenger pathway. Brain Res. 546 : 83 95.
32. Witte, E.A. & R.T. Marrocco. 1997. Alterations of brain noradrenergic activity in rhesus monkeys affects the alerting component of covert orienting. Psychopharmacology 132 : 315 323.
33. Coull, J.T., A.C. Nobre & C.D. Frith. 2001. The noradrenergic alpha2 agonist clonidine modulates behavioural and neuroanatomical correlates of human attentional orienting and alerting. Cereb. Cortex 11 : 73 84.
34. Brozoski, T. et al. 1979. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205 : 929 931.
35. Arnsten, A.F.T. & T.W. Robbins. 2002. Neurochemical modulation of prefrontal cortical function in humans and animals. In Principles of Frontal Lobe Function. D.T. Stuss & R.T. Knight, Eds 51 84. Oxford University Press. New York.
36. Arnsten, A.F.T. & B.-M. Li. 2005. Neurobiology of executive functions: catecholamine influences on prefrontal cortical function. Biol. Psychiatry 57 : 1377 1384.
37. Schultz, W. 1998. The phasic reward signal of primate dopamine neurons. Adv. Pharmacol. 42 : 686 690.
38. Arnsten, A.F.T. & P.S. Goldman-Rakic. 1985. Alpha-2 adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates. Science 230 : 1273 1276.
39. Cai, J.X. et al. 1993. Reserpine impairs spatial working memory performance in monkeys: reversal by the alpha-2 adrenergic agonist clonidine. Brain Res. 614 : 191 196.
40. Franowicz, J.S. et al. 2002. Mutation of the alpha2A-adrenoceptor impairs working memory performance and annuls cognitive enhancement by guanfacine. J. Neurosci. 22 : 8771 8777.
41. Birnbaum, S.G. & A.F.T. Arnsten. 1996. The alpha-2A noradrenergic agonist, guanfacine, reverses the working memory deficits induced by pharmacological stress (FG7142). Soc. Neurosci. Abstr. 22 : 1126.
42. Arnsten, A.F.T. & T.A. Contant. 1992. Alpha-2 adrenergic agonists decrease distractability in aged monkeys performing a delayed response task. Psychopharmacology 108 : 159 169.
43. Steere, J.C. & A.F.T. Arnsten. 1997. The alpha-2A nor-adrenergic agonist, guanfacine, improves visual object discrimination reversal performance in rhesus monkeys. Behav. Neurosci. 111 : 1 9.
44. Mao, Z.-M., A.F.T. Arnsten & B.-M. Li. 1999. Local infusion of alpha-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys. Biol. Psychiatry 46 : 1259 1265.
45. Wang, M., J.Z. Ji & B.M. Li. 2004. The alpha(2A)-adrenergic agonist guanfacine improves visuomotor associative learning in monkeys. Neuropsychopharmacology 29 : 86 92.
46. Jakala, P. et al. 1999. Guanfacine, but not clonidine, improves planning and working memory performance in humans. Neuropsychopharmacology 20 : 460 470.
47. Li, B.-M. et al. 1999. Alpha-2 adrenergic modulation of prefrontal cortical neuronal activity related to spatial working memory in monkeys. Neuropsychopharmacology 21 : 601 610.
48. Wang, M. et al. 2007. Alpha2A-adrenoceptor stimulation strengthens working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex. Cell 129 : 397 410.
49. Li, B.-M. & Z.-T. Mei. 1994. Delayed response deficit induced by local injection of the alpha-2 adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeys. Behav. Neural. Biol. 62 : 134 139.
50. Ma, C.-L. et al. 2003. Selective deficit in no-go performance induced by blockade of prefrontal cortical alpha2-adrenoceptors in monkeys. Neuroreport 14 : 1013 1016.
51. Ma, C.-L., A.F.T. Arnsten & B.-M. Li. 2005. Locomotor hyperactivity induced by blockade of prefrontal cortical alpha-2-adrenoceptors in monkeys. Biol. Psychiatry 57 : 192 195.
52. Hunt, R.D., A.F.T. Arnsten & M.D. Asbell. 1995. An open trial of guanfacine in the treatment of attention deficit hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 34 : 50 54.
53. Scahill, L. et al. 2001. Guanfacine in the treatment of children with tic disorders and ADHD: a placebo-controlled study. Am. J. Psychiatry 158 : 1067 1074.
54. Taylor, F.B. & J. Russo. 2001. Comparing guanfacine and dextroamphetamine for the treatment of adult attention deficit-hyperactivity disorder. J. Clin. Psychopharm. 21 : 223 228.
55. Birnbaum, S.B. et al. 2004. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306 : 882 884.
56. Arnsten, A.F.T. et al. 1999. Alpha-1 noradrenergic receptor stimulation impairs prefrontal cortical cognitive function. Biol. Psychiatry 45 : 26 31.
57. Arnsten, A.F.T. & J.D. Jentsch. 1997. The alpha-1 adrenergic agonist, cirazoline, impairs spatial working memory performance in aged monkeys. Pharmacol. Biochem. Behav. 58 : 55 59.
58. Birnbaum, S.G. et al. 1999. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in prefrontal cortex. Biol. Psychiatry 46 : 1266 1274.
59. Raskind, M.A. et al. 2003. Prazosin reduces nightmares and other PTSD symptoms in combat veterans: a placebo-controlled study. Am. J. Psychiatry 160 : 371 373.
60. Manji, H.K. & R.H. Lenox. 1999. Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol. Psychiatry 46 : 1328 1351.
61. Williams, N.M. et al. 2004. Support for RGS4 as a susceptibility gene for schizophrenia. Biol. Psychiatry 55 : 192 195.
62. Baum, A.E. et al. 2008. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol. Psychiatry 13 : 197 207.
63. Biederman, J. et al. 2000. Pediatric mania: a developmental subtype of bipolar disorder? Biol. Psychiatry 48 : 458 466.
64. Ramos, B. et al. 2005. The beta-1 adrenergic antagonist, betaxolol, improves working memory performance in rats and monkeys. Biol. Psychiatry 58 : 894 900.
65. Van Tol, H.H.M. et al. 1991. Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine. Nature 350 : 610 614.
66. Goldman-Rakic, P.S., M.S. Lidow & D.W. Gallager. 1990. Overlap of dopaminergic, adrenergic, and serotonergic receptors and complementarity of their subtypes in primate prefrontal cortex. J. Neurosci. 10 : 2125 2138.
67. Smiley, J.F. et al. 1994. D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc. Natl. Acad. Sci. USA 91 : 5720 5724.
68. Wang, J. & P. O'Donnell. 2001. D(1) dopamine receptors potentiate nmda-mediated excitability increase in layer V prefrontal cortical pyramidal neurons. Cereb. Cortex 11 : 452 462.
69. Seamans, J.K. et al. 2001. Dopamine D1/D5 receptor modulation of excitatory synaptic inputs to layer V prefrontal cortex neurons. Proc. Natl. Acad. Sci. USA 98 : 301 306.
70. Young, C.E. & C.R. Yang. 2004. Dopamine D1/D5 receptor modulates state-dependent switching of soma-dendritic Ca2+ potentials via differential protein kinase A and C activation in rat prefrontal cortical neurons. J. Neurosci. 24 : 8 23.
71. Arnsten, A.F.T. et al. 1994. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology 116 : 143 151.
72. Granon, S. et al. 2000. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J. Neurosci. 20 : 1208 1215.
73. Lidow, M.S., P.-O. Koh & A.F.T. Arnsten. 2003. D1 dopamine receptors in the mouse prefrontal cortex: immunocytochemical and cognitive neuropharmacological analyses. Synapse 47 : 101 108.
74. Zahrt, J. et al. 1997. Supranormal stimulation of dopamine D1 receptors in the rodent prefrontal cortex impairs spatial working memory performance. J. Neurosci. 17 : 8528 8535.
75. Arnsten, A.F.T. & P.S. Goldman-Rakic. 1998. Noise stress impairs prefrontal cortical cognitive function in monkeys: evidence for a hyperdopaminergic mechanism. Arch. Gen. Psychiatry 55 : 362 369.
76. Mattay, V.S. et al. 2003. Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. USA 100 : 6186 6191.
77. Vijayraghavan, S. et al. 2007. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 10 : 376 384.
78. Kimberg, D.Y., M. D'Esposito & M.J. Farah. 1997. Effects of bromocriptine on human subjects depend on working memory capacity. Neuroreport 8 : 3581 3585.
79. Sawaguchi, T. & P.S. Goldman-Rakic. 1994. The role of D1-dopamine receptors in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed response task. J. Neurophysiol. 71 : 515 528.
80. Druzin, M.Y. et al. 2000. The effects of local application of D2 selective dopaminergic drugs into the medial prefrontal cortex of rats in a delayed spatial choice task. Behav. Brain Res. 109 : 99 111.
81. Wang, M., S. Vijayraghavan & P.S. Goldman-Rakic. 2004. Selective D2 receptor actions on the functional circuitry of working memory. Science 303 : 853 856.
82. Ford, J.M. et al. 2002. Reduced communication between frontal and temporal lobes during talking in schizophrenia. Biol. Psychiatry 51 : 485 492.
83. Mrzljak, L. et al. 1996. Localization of dopamine D4 receptors in GABAergic neurons of the primate brain. Nature 381 : 245 248.
84. Wang, X., P. Zhong & Z. Yan. 2002. Dopamine D4 receptors modulate GABAergic signaling in pyramidal neurons of prefrontal cortex. J. Neurosci. 22 : 9185 9193.
85. Tahir, E. et al. 2000. Association and linkage of DRD4 and DRD5 with attention deficit hyperactivity disorder (ADHD) in a sample of Turkish children. Mol. Psychiatry 5 : 396 404.
86. Sunohara, G.A. et al. 2000. Linkage of the dopamine D4 receptor gene and attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry 39 : 1537 1542.
87. Arnsten, A.F.T. 2000. Through the looking glass: differential noradrenergic modulation of prefrontal cortical function. Neural Plasticity 7 : 133 146.
88. Arnsten, A.F.T. 2000. Stress impairs PFC function in rats and monkeys: role of dopamine D1 and norepinephrine alpha-1 receptor mechanisms. Prog. Brain Res. 126 : 183 192.
89. Faraone, S.V. et al. 2005. Molecular genetics of attention-deficit/ hyperactivity disorder. Biol. Psychiatry 57 : 1313 1323.
90. Daly, G. et al. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol. Psychiatry 4 : 192 196.
91. Durston, S. et al. 2005. Differential effects of DRD4 and DAT1 genotype on fronto-striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatry 10 : 678 685.
92. Bobb, A.J. et al. 2005. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 134 : 67 72.
93. Roman, T. et al. 2002. Further evidence for the association between attention-deficit/hyperactivity disorder and the dopamine-beta-hydroxylase gene. Am. J. Med. Genet. 114 : 154 158.
94. Kim, C.H. et al. 2006. A polymorphism in the nor-epinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl. Acad. Sci. USA 103 : 19164 19169.
95. Comings, D.E. 2001. Clinical and molecular genetics of ADHD and Tourette syndrome. Two related polygenic disorders. Ann. N. Y. Acad. Sci. 931 : 50 83.
96. Roman, T. et al. 2003. Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder? Am. J. Med. Genet. B. Neuropsychiatr. Genet. 120 : 116 120.
97. Park, L. et al. 2005. Association and linkage of alpha-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol. Psychiatry 10 : 572 580.
98. Deupree, J.D. et al. 2006. Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141 : 877 884.
99. Turner, D.C. et al. 2005. Neurocognitive effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology 178 : 286 295.
100. Elliott, R. et al. 1997. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology 131 : 196 206.
101. Mehta, M.A. et al. 2000. Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J. Neurosci. 20 : RC651 RC656.
102. Kuczenski, R. & D.S. Segal. 2002. Exposure of adolescent rats to oral methylphenidate: preferential effects on extracellular norepinephrine and absence of sensitization and cross-sensitization to methamphetamine. J. Neurosci. 22 : 7264 7271.
103. Berridge, C.W. et al. 2006. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biol. Psychiatry 60 : 1111 1120.
104. Arnsten, A.F.T. & A.G. Dudley. 2005. Methylphenidate improves prefrontal cortical cognitive function through a2 adrenoceptor and dopamine D1 receptor actions: relevance to therapeutic effects in attention deficit hyperactivity disorder. Behav. Brain Funct. (Biomed. Central) 1 : 2.
105. Bymaster, F.P. et al. 2002. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 27 : 699 711.